Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs Intrathecal Dexmedetomidine for Spinal Block
NCT06654531Phase 3Completed
- Sponsor
- Al-Azhar University
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in postoperative pain, sponsored by Al-Azhar University. Started Jan 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06654531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06654531.